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ABSTRACT
Opioid abuse among Certified Registered Nurse Anesthetists (CRNAs) and
Student Registered Nurse Anesthetists (SRNAs) is an epidemic that is growing in
numbers yearly. The number of deaths from opioid abuse is also increasing. The specialty
of anesthesia primarily has increased instances of opioid abuse cases (Wright et al.,
2012). The reason for the increase in opioid abuse occurrences is because anesthesia
providers regularly administer opioids in patient care. Opioid abuse commonly results in
injury or death. While abusing, anesthesia providers are not only putting their lives in
jeopardy but also the lives of their patients.
The project observed the opioid abuse that is affecting the anesthesia community.
The project also suggested a policy change at The University of Southern Mississippi that
can increase the required drug screenings for student registered nurse anesthetists from
once a year to twice a year. This change will be done in hopes of identifying abuse early
in order to intervene appropriately.
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CHAPTER I - INTRODUCTION
Problem Description
According to the Centers for Disease Control (CDC, 2016), opioids were
responsible for killing more than 42,000 people in the United States in 2016. The number
of overdose deaths involving opioids (including prescription opioids and heroin) was 5
times higher than in 1999 (CDC, 2016). On average, 116 people die every day from an
opioid overdose (CDC, 2016). According to the CDC, nearly half of all opioid overdose
deaths involve a prescription opioid. The number of prescription opioids sold to
pharmacies, hospitals, and doctors’ offices nearly quadrupled from 1999 to 2010 despite
no change in the overall amount of pain that Americans have reported (CDC, 2016).
Deaths from prescription opioids overdose have more than quadrupled since 1999. The
word ‘epidemic’ can be defined as affecting or tending to affect a disproportionately
substantial number of individuals within a population, community, or region at the same
time (Merriam-Webster Online, 2018). The previously stated statistics constitute an
opioid epidemic.
Approximately 40% of all United States (U.S) opioid overdose deaths involve a
prescription opioid (CDC, 2016). In 2016, over 46 people died each day because of
prescription opioid overdose (CDC, 2016). The three commonly abused medications
were methadone, oxycodone (OxyContin), and hydrocodone (Vicodin). Fentanyl and
heroin are the two most commonly used drugs that are not on the prescribed opioid list
(CDC, 2016). Fentanyl is a synthetic opioid pain reliever, approved for treating severe
pain such as advanced cancer pain. It is a drug of choice for abusers because it is 50-100
times more potent than Morphine (Gladden, Martinez, & Seth, 2013). Heroin is an illegal,
1

highly-addictive opioid drug that can be injected, smoked, and snorted. Unfortunately,
this drug can result in multiple long-term viral infections such as HIV, Hepatitis C, and
Hepatitis B, as well as bacterial infections of the skin, bloodstream, and heart (CDC,
2016).
With opioid abuse impacting the public, healthcare providers abusing them is also
a concern. A 1999 study by Bell, McDonough, Ellison, and Fitzhugh was the first largescale study that looked at the prevalence of substance abuse among nurse anesthetists and
student nurse anesthetists. The study revealed 10% of these providers admitted to
misusing anesthetic medications during their careers (Wright et al., 2012). According to
those statistics, one in every ten anesthesia providers abusing anesthetic medications.
Literature supports that the abuse of potent opioids is at an all-time high and is greater in
student registered nurse anesthetists (SRNAs) and other anesthesia providers than the
general population of healthcare providers (Wright et al., 2012).
Available Knowledge
Abuse is usually not recognized until a fatal or nearly fatal overdose occurs
(Wright et al., 2012). Anesthesia providers are at an elevated risk of abuse because drugs
can be stolen readily from anesthesia services. Drug abuse by hospital staff members not
only jeopardizes the user’s patients but also threatens the user with loss of license,
incapacity, and death (Gravenstein, Kory, & Marks, 1983).
Shifting the focus to the SRNA has the potential to impact abuse issues and
possibly save lives. A study based on mortality risk of anesthesia providers reported that
most drug-related deaths for providers occurred during the first five years after
graduation (Alexander, Checkoway, Nagahama, & Domino, 2000). The study helps to
2

support the claim that there is a problem with abusers beginning abuse early on in their
careers. Multiple reasons can explain why the abuse begins in this phase of one’s career
and develops into a full-blown addiction. Explanations for early abuse include
neurobiological factors, physiological changes, and personality traits (Wright et al.,
2012).
Personal characteristics described in opioid abuse among SRNAs include
neurobiological factors. These factors entail addiction caused by changes in the brain
involving alterations in the neurotransmission of the reward system (Casey, 2017;
McDonough, 1990; Wright et al., 2012). Compelling evidence supports a genetic
susceptibility to addictive behavior. A person who has substance abuse in their genetics is
more likely to abuse opioids. Personality factors arise from providers with sensation
seeking or impulsive traits (Casey, 2017; McDonough, 1990; Wright et al., 2012).
Behavior characteristics deal with the psychological factors including abuse of moodaltering substances for self-treatment of underlying psychological disorders
(McDonough, 1990; Wright et al., 2012). Abuse among anesthesia providers is
sometimes related to a traumatic experience or emotional event (Wright et al., 2012).
The purpose of this doctoral project was to propose a more intricate measure to
identify opioid abuse among SRNAs. A measure to complete the goal at hand is to
implement a change in the process used to identify opioid abuse. More specifically, the
change would require an increase in the number of random drug screenings in the
program to identify potential opioid abuse among students enrolled in The University of
Southern Mississippi’s (USM) Nurse Anesthesia Program (NAP).
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Synthesis of Knowledge
A thorough review was completed of eight relevant articles on the topic of opioid
abuse that were specific to the population of anesthesia providers. These articles provided
further insight into abuse potential. A common finding in the literature was the
suggestion for firmly enforcing regulation with the approval of random urine screening of
anesthesia providers (Booth et al., 2002; Bozimowski, Groh, Rouen, & Dosch, 2014). An
article by Wright and colleagues (2012) described a survey that illustrated the outcome of
opioid abuse among anesthesia providers. The survey was sent to 250 nurse anesthetists
in recovery for opioid abuse. Only 61 anesthesia providers responded after having reentered the field of anesthesia. All the past abusers identified that the most helpful factor
to successful reentry was random drug screening (Bozimowski et al., 2014; Bryson &
Hamza, 2011; Wright et al., 2012).
Random drug screenings are required for nurse anesthesia students before the start
of their programs. The drug screens must be in accordance with the Substance Abuse
Mental Health Service Administration (SAMHSA) guidelines (Substance Abuse and
Mental Health Services Administration [SAMHSA], 2018). Implementing random testing
is essential among anesthesia providers to reduce the incidence of diversion and detect an
individual early on in their addiction before it progresses (Bozimowski et al., 2014;
Bryson & Hamza, 2011; Wright et al., 2012). The implementation of random screening
would increase safety among anesthesia providers and decrease the number of reportable
cases of opioid abuse.
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Context
In attempts to determine the predisposing risks, the pre-enrollment procedure for
entrance into programs was observed. According to the literature, the two most common
pre-enrollment criteria among most programs are background checks and drug testing
(Bryson & Silverstein, 2008). Some measures used for SRNAs to prevent substance
abuse include wellness promotion education at the start of their program (American
Association of Nurse Anesthetists [AANA], 2018). Through wellness education, students
are expected to acknowledge the potential dangers of opioid abuse and addiction in the
healthcare setting.
Wellness programs have not been able to control the numbers associated with
opioid abuse among anesthesia providers (Sensenbrenner, 2016). Federal Bill 5046 is
also known as the Comprehensive Opioid Abuse Reduction Act of 2016. The Act awards
grants to state, local, and tribal governments to provide opioid abuse services including
different programs and peer-to-peer services (Sensenbrenner, 2016). Although the Act
has been in place since 2016, it has not decreased the number of opioid abuse cases as
evidenced by the increasing cases of abuse.
Interventions
A possible solution to identifying drug abusers is more frequent urine drug
screens. USM School of Leadership and Advanced Nursing Practice’s Alcohol and Drug
Screening Policy (SON1053) requires urine drug screens once every 12 months. The
policy change proposal to increase the random urine drug screens from once a year to
twice a year can possibly increase the odds of identifying opioid abusers. Students need
to refer to the NAP’s Policy and Procedures Manual concerning disclosure about
5

prescription medications. According to the policy, students who are prescribed
medications for ADHD, anxiety, depression, chronic pain, antihistamines, mood-altering
substances, or any other medication that would be revealed on a drug screen must provide
a copy of their prescription to the Nurse Anesthesia Program Director and to the Director
of Student Services (University of Southern Mississippi, 2017). The disclosure ensures
that the student is protected if their drug screen tests positive for the previously
mentioned medications. By implementing more frequent urine drug screens in NAPs,
more drug misusers can be identified.
Rationale
A Logic Model was used in the development of this project’s idea. The focus of
the model was to develop a picture to indicate how parts of a program are linked together
or how it will work (Zaccagnini & White, 2011). The model was made up of inputs,
activities, outputs, outcomes, and impact (Zaccagnini & White, 2011).
The input of the Logic Model are resources required to implement and evaluate the
project (Zaccagnini & White, 2011). The input of the Logic Model includes SRNAs,
USM’s NAP, the Routine and Controlled Substance Policy, and urine drug screens. The
activities are what the project does with the resources to achieve the intended outcomes
(Zaccagnini & White, 2011). The activities utilized in this model include students being
verbally informed of the change in policy and being educated on the need for change in
policy. The outputs are the immediate results of the project (Zaccagnini & White, 2011).
The outputs were the NAP implementing the policy change and adherence of the new
policy by the SRNAs in the NAP. The outcomes are set in three levels: short term,
intermediate term, and long-term goals. A short-term goal was for the student to
6

acknowledge the policy change. An intermediate goal would be to decrease opioid
misuse reports among SRNAs and to increase prescriptions on file for prescribed
medications. A long-term goal would be the policy change enacted in more schools and
ultimately decrease in opioid misuse reports among SRNAs nationally. The impact of the
model would be to decrease of possible harm of providers and patients from abusers.
Another impact would be for other nurse anesthesia programs to identify opioid abusers
earlier, and ultimately a decrease in opioid abuse (Appendix A).
Specific Aims
The goal of the project was to enact policy change in USM’s NAP. Safe and
efficacious delivery of anesthesia requires constant alertness and rapid response to
potentially harmful changes in patient status. Any variable that may cause alterations in
an anesthesia provider’s degree of vigilance, such as drug-induced impairment, can
seriously compromise the safety of the patient and greatly impact their outcome (Bell et
al., 1999). Anything ensuring patient safety was regarded as the number one priority
(Wright et al., 2012).
Summary
Opioid abuse is at an all-time high and it is affecting anesthesia providers in the
United States. Studies have illustrated that 10% of providers have admitted to misusing
anesthetic medications during their careers (Wright et al., 2012). Implementing random
drug screening is essential among anesthesia providers to reduce the incidence of
diversion and detect an individual early on in their addiction before it progresses
(Bozimowski et al., 2014; Bryson & Hamza, 2011; Wright et al., 2012). Efforts to
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discover abuse early in the career can be realized at USM by increasing the drug
screening policy from once a year to twice a year.
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CHAPTER II – METHODOLOGY
Drafting a Policy
Drafting a policy includes following a standard format to ensure consistency
between policies. First, a policy number must be assigned. Despite revisions to future
policies, this number remains unchanged (Policy and Procedures Writing Guide, 2018).
Next, an effective and revised date must be devised. The policy must have a title that
includes the content of the policy. The purpose of the policy should encompass a brief
statement that includes a basic explanation. Additional authority states the list of statute,
regulation, State Board policy, Executive Order, or other relevant authority governing the
policy (Policy and Procedures Writing Guide, 2018). The scope of the policy identifies to
whom the policy applies. The responsible party lists the unit, school, college, or another
area responsible for enforcing the policy. Finally, definitions should be added to clarify
uncommon words or words with meanings unique to higher education and/or nursing
(Policy and Procedures Writing Guide, 2018). According to these recommendations, the
policy that the NAP has on controlled substance use currently follows all these
guidelines.
The Alcohol and Drug Screening Policy (SON1053) was written to include an
additional urine drug screen a year. The desired change in policy requires students to do
two random urine drug screens a year, instead of one screening a year. The other existing
guidelines remained in place. Lab Depot continues to be the primary medical lab of
testing for the Hattiesburg and Gulf Coast campus.
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Panel of Experts
Once the change in policy was drafted, a panel of experts reviewed the new
policy. The panel included four professionals, including two NAP administrators, one
USM College of Nursing and Health Professions (CONHP) Associate Dean, and one
USM legal representative. The expert panel was given a short questionnaire with five
multiple choice questions. The questions detailed the panels’ opinions on their answers to
the questions.
Suggested Policy
According to The University of Southern Mississippi’s current drug screening
policy called the Alcohol and Drug Screening Policy (SON1053), every undergraduate
and graduate student enrolled in a clinical nursing course is required to undergo a
controlled substance screening test at least once every 12 months (The University of
Southern Mississippi, 2017). The policy previously mentioned requires that every
undergraduate and graduate student enrolled in a clinical nursing course is required to
undergo alcohol and drug-screening. The results of the screening must be on file onemonth prior to the first day of courses (University of Southern Mississippi, 2017). These
requirements do not exactly follow the random screening rule. The proposal was to
increase the frequency of drug screenings from one to two random drug screenings a year
for graduate students in the NAP (Appendix B).
Tool
The panel of experts were given a questionnaire with five multiple choice
questions. The five questions asked included:
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1. Are you familiar with the current Alcohol and Drug Screening Policy
(SON1053)?
2. Do you agree with the current Alcohol and Drug Screening Policy
(SON1053)?
3. Do you feel that the proposed change in policy will make a difference?
4. How often should urine screenings be conducted?
5. Do you think this policy can make an impact amongst SRNAs that are
currently abusing opioids?
Analysis
After the panel of experts answered the previous questions, their results were
carefully analyzed. It was calculated based on percentages. After exploring the makings
of a policy, drafting a revision of the original policy, and asking the panel to complete a
survey concerning the change in policy, the final step was to implement the policy
revision.
A NAP in the southeast region of the United States has been open since 2012.
There have been 120 students to matriculate through the NAP as of this date. Two
students have been terminated for misuse of medications. After the implementation of the
policy change, the Program Coordinator may observe a change in the prevalence of
opioid abuse in their program.
Ethical Considerations
The Nuremberg Code of 1947 made voluntary consent of human subject essential
(Shuster & Shuster, 1997). The project did not include the study of any human subjects;
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therefore, there were no direct violations of ethical principles. The sole purpose of the
project was to implement policy change.
Summary
The desired change in policy requires students to do two random urine drug
screens a year, instead of one screening a year. The change in policy was presented to a
panel of experts. The panel included four professionals, including two NAP
administrators, one USM CONHP Associate Dean, and one USM legal representative.
Once the panel was identified, they were given a short questionnaire with five multiple
choice questions. The results of the survey were carefully analyzed and later discussed.
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CHAPTER III - RESULTS
The data from the panel of experts’ questionnaires were gathered. Three of the
four panelists completed their questionnaires. One of the panelists did not respond. From
the three panelists that did respond, all three claimed to be familiar with the current drug
screen policy, the Routine and Controlled Substance Policy (SON1053). Two of the three
panelists did not agree with the current drug screen policy. Two of the panelists agreed
that the drug screening policies should be changed to two times a year at random. All
three panelists did, however, agree that a change in the current policy will make a
difference in detection of students who are abusing subastances and have an impact in the
amount of SRNAs currently abusing substances.
Summary
After analyzing the feedback received from the questionnaire that was completed
by the panel of experts, their opinions were calculated based on percentages. The
response rate from the panel of experts was 75%. From the panelists who responded to
the request, all were familiar with the existing controlled substance policy (SON 1053).
66.6% did not agree with the current drug screen policy. Most agreed (66.6%) agreed that
the drug screening policies should be changed to two times a year at random. All (100%)
participants agreed that a change in the current policy will make a difference in detection
of opioid abuse among students and will also have an impact on the amount of SRNAs
currently abusing substances.
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CHAPTER IV – DISCUSSION
Summary
According to the data collected from the questionnaire, the change in the drug
screening policy for the Nurse Anesthesia Program was favored. The change in policy
was viewed as a draft by the committee and chair, and the anticipated outcome is that the
policy can be proposed to the USM NAP Director, USM CONHP Associate Dean, and
one USM legal representative.
Interpretations
There were factors to consider when dealing with the data received from the
questionnaires. The biggest skew in data could be because not everyone on the panel
completed the questionnaire. The panel of experts was meticulously chosen because all
four individuals have the potential to influence a change of policy at USM. The panel
included two NAP faculty, one USM CONHP Associate Dean, and one USM legal
representative. The USM legal representative’s vote was not reflected among the
collected data. One may wonder if the last panelist would have agreed or disagreed with
the change in policy.
Another factor that may skew the results would be that two of the panelists were
NAP faculty. The fact that 50% of the panel were leaders in the NAP may affected the
results based on their involvement. Also, they are more closely affected by opioid abuse
among SRNAs. The makeup of the panel was intended to elicit differing opinions on this
proposed policy change.
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Limitations
According to the Substance Abuse and Mental Health Services Administration,
the overall rate for substance abuse in the general population is 8% (Wright et al., 2012).
Many factors can affect these numbers. With the sensitivity of legal issues associated
with practice, many anesthesia providers may be harshly disciplined if discovered to be
abusing opioids (Wright et al., 2012). Due to the need to protect staff and students, it was
likely that the scope of this problem was underestimated. It is possible that we will never
know how prevalent opioid addiction is in the population discussed.
Privacy concerns by students may be of concern for the SRNA. The Health
Insurance Portability and Accountability Act (HIPAA) includes provisions that require
the U.S. Health and Human Services to adopt national standards for electronic health care
transactions and code sets, unique health identifiers, and security (U.S. Department of
Health and Human Services, 2018). Congress incorporated HIPAA provisions that
authorized the adoption of Federal privacy protections for individually identifiable health
information. If a student has a history of abuse, it is not disclosed to other schools during
their application process. Knowledge of these accusations are often kept confidential
from the public.
Failure to report was another limitation that was to be addressed. Most students
will not want to report their peers or events they may have witnessed because of potential
consequences. The reporting student may be labeled as a “rat” or a liar. A student who is
abusing substances may not want to report themselves because of the consequences. They
are at risk of being dismissed from their program and may possibly lose their opportunity
to further their education in anesthesia.
15

A major limitation encountered while researching this project was gaining the
approval of the Office of General Counsel at USM. The concept of this project had been
previously introduced to the General Counsel’s office and was denied. After introducing
new evidence and ideas, approval of the policy change was desired.
Conclusions
Was the policy change worth it? Can the policy change make a difference? One
comment that was made from a panelist was their concern for students and the cost of an
extra drug screen each year. Cost was something to consider when proceeding with the
implementation of policy change. Ultimately, a majority of the panel was in favor of the
policy change with the data derived from the questionnaire. The plan for the project was
to begin in the NAP at USM and extend to other NAPs around the nation who are
affected by opioid abuse. This option is just one more step that is taken to ensure patient
and provider safety in the hospital setting.
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APPENDIX A – Logic Map
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APPENDIX B – Revised Policy

SCHOOL OF LEADERSHIP AND ADVANCED NURSING PRACTICE
Policy Area: NAP Student
Subject: Course Information
Title of Policy: Alcohol and Drug
Number: CONth1053
Screening
Effective Date: Fall 2019
Supersedes:
Approved Date:
Approved by:
Revision Date: June 2019

1. Rationale or background to policy: The School of Leadership and Advanced Nursing
Practice at The University of Southern Mississippi has a vital interest in maintaining a
safe, healthy, and efficient environment for its faculty, staff, and students in an
environment free from the misuse of drugs and alcohol. Such misuse of drugs and alcohol
is detrimental to the physical and psychological wellbeing of nursing students, and in
turn, to the safety of their patients. Therefore, every graduate student enrolled in a
clinical nursing course is required to undergo two random alcohol and drug-screening
test at least twice every twelve months and may undergo additional alcohol and drug
screenings depending upon the circumstances.
2. Policy Statement: All graduate NAP students must produce a negative alcohol and
drug screening test before admission and bi-annually while in a College of Nursing and
Health Professions. Testing and results must be managed according to the procedure
outlined below.
3. Procedure for Annual Alcohol/Drug Screen
The student is responsible for the following:
1. Scheduling the 11-point urine screening test at a local hospital or laboratory entity
independent of The University of Southern Mississippi (USM). The College of Nursing
and Health Professions recommends the following labs:
a. Lab Test Depot for the Hattiesburg campus
b. Lab Test for the Gulf Coast campus.
Students may choose any lab entity independent of The University of Southern
Mississippi. However, if a lab other than the School recommended labs are used, prior
18

approval must be obtained from the Office of Student Services in the College of Nursing
and Health Professions on the Hattiesburg Campus.
Drug testing should be performed for, but not limited to, the presence of cannabinoids,
cocaine, opiates, amphetamines, barbiturates, benzodiazepines, propoxyphene,
phencyclidine (PCP), methadone, methaqualone, MDMA (ecstasy), or metabolites of any
such substance.
2. Assuring that the laboratory distributes the results by mail or fax, they should be
sent directly to the College of Nursing and Health Professions, Office of Student
Services on the Hattiesburg campus: 601-266-6144 (fax) or
Assistant to the Dean for Academic Records & Advisement
Student Services College of Nursing and Health Professions
The University of Southern Mississippi
118 College Drive #5095
Hattiesburg, MS 39406
3. Paying for the alcohol and drug screening test and confirmation.
4. Assuring that results are on file with the Associate Dean, Dr. Lachel Story, via the
College of Nursing and Health Professions Student Services office one month prior to
the first day of the semester for new admission and bi-annually thereafter.
Note: Results may take up to 2 weeks to reach the College of Nursing and Health
Professions. Students must plan accordingly.
5. An alcohol and drug test from a student’s employer will be accepted if it meets the
above criteria.
6. No student will be allowed to continue in a clinical nursing course and/or participate in
College of Nursing and Health Professions activities at an associated health care agency
until the results of the alcohol and drug screening test have been submitted to and are on
file at the College of Nursing and Health Professions.
7. If the results of the alcohol and drug-screening test are positive, the student must not
continue in nursing courses. The student will have access to due process to contest the
screening results using the Breach of Impaired Nursing Student and Professional Conduct
Policy. Students who do not choose to pursue due process through the Breach of
Professional Conduct and Impaired Nursing Student Policy must withdraw from the
College of Nursing and Health Professions.
8. If a student refuses to submit to a routine controlled substance screen, he/she will not
be allowed to continue in a clinical nursing course and/or participate in the College of
Nursing and Health Professions activities with associated health care agencies.
19

9. The faculty defines a graduate clinical nursing course as a combination of theory and
clinical experiences. These two components are inseparable. Clinical nursing courses
include theory and co-requisite lab/clinical courses and stand-alone clinical practicums
(e.g., preceptorship, clinical practicums) in all graduate nursing programs of study.

*The italicized, underlined, and bolded words are the changes made from the original
policy.
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APPENDIX C – Institutional Review Board Response
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